Frequency ExchangeFRECF -32.52%8 3-Year EBITDA Growth Rate is 38.00% as of Mar. 2026. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.07 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 695 Medical Devices & Instruments companies, Frequency Exchange ranks better than 83.02% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 38.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -61.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Frequency Exchange was 38.00% per year. The lowest was -126.80% per year. And the median was -102.70% per year.
Frequency Exchange (OTCPK:FRECF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Frequency Exchange 3-Year EBITDA Growth Rate Related Terms
FRECF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Frequency Exchange's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's 3-Year EBITDA Growth Rate falls into.
Frequency Exchange 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 38.00% mean?
Frequency Exchange (FRECF) has a 3-Year EBITDA Growth Rate of 38.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Frequency Exchange and its competitors. According to the industry distribution chart, Frequency Exchange ranks #118 out of 695 companies in the Medical Devices & Instruments industry, placing it in the top 17%.
Is Frequency Exchange's 3-Year EBITDA Growth Rate too high?
Frequency Exchange's current 3-Year EBITDA Growth Rate is 38.00%. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.90. Frequency Exchange's value of 38.00% is 381% above this industry median. Based on the distribution chart, Frequency Exchange ranks #118 out of 695 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #118 out of 695 companies for 3-Year EBITDA Growth Rate. This places Frequency Exchange in the top 17% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 7.90. Frequency Exchange's value of 38.00% is 381% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.90, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frequency Exchange's current 3-Year EBITDA Growth Rate of 38.00% is 381% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Frequency Exchange and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frequency Exchange's current 3-Year EBITDA Growth Rate is 38.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.07, compared to a current price of $0.16 — trading 128.6% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 38.00% and 381% above the Medical Devices & Instruments industry median of 7.90. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current 3-Year EBITDA Growth Rate is 38.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.16 is trading 128.6% above its estimated GF Value™ of $0.07.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
3-Year EBITDA Growth Rate: 38.00%
GF Value™: $0.07 vs. price of $0.16 (128.6% above fair value)
Industry Position: 381% above the Medical Devices & Instruments median (#118 of 695)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 